Innovation is at the heart in the development of new drugs

Orexo is a company built on the principle of innovation, fueled by the interplay between researchers and experts with different scientific backgrounds. Today innovation remains at the core of the work of continuing to develop improved drugs to benefit patients worldwide.

Culture

Orexo has created a workspace with an open-minded environment where new product ideas are captured from all across the organization. In our view, transparency and multifunctional interactions are key drivers for establishment of an innovation culture. Orexo strives to initiate product development internally and maintain full control of the development process. However, we are increasingly working with external partners where our drug delivery technology can contribute to improving other companies' APIs.

Talents

Orexo is a fully integrated specialty pharmaceutical company with expert competence in a multitude of scientific disciplines. Our talents are continuously fostered and advanced through individually compiled development plans. With the patient in focus, Orexo’s innovative drug development process is characterized by engagement, flexibility, and simplicity.

Process

Project and product ideas are captured by all employees within the organization. All ideas are evaluated and prioritized regarding e.g., which unmet medical need is addressed, technical feasibility, patentability, and commercial potential. This process is enabled by the multifunctional interplay between researchers, experts, and commercial functions and is a key to success.

Value

As a result of an innovative culture, talents, and transparent processes, Orexo has been able to create a unique track record of developing proprietary innovative products with significant value for patients and societies around the world. To date Orexo has developed four products, Zubsolv®, Abstral®, Edluar® and Diabact® [1], which have been approved in multiple countries across the world.